Produkty 2204-13-9

CAS 2204-13-9 występuje w naszej ofercie pod nazwami: (3Beta,20R)-Pregn-5-ene-3,17,20-triol, >95% (HPLC), (3b,20R)-Pregn-5-ene-3,17,20-triol. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 50mg, 5mg, 2mg, 10mg, 25mg.

(3Beta,20R)-Pregn-5-ene-3,17,20-triol, >95% (HPLC)
TRC
  • opakowanie: 50mg, 5mg
  • Warianty: 2
Zobacz produkt
(3b,20R)-Pregn-5-ene-3,17,20-triol
Biosynth
  • opakowanie: 2mg, 5mg, 10mg, 25mg
  • Warianty: 5
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,8R,9S,10R,13S,14S,17R)-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol (CAS 2204-13-9) to związek chemiczny o wzorze sumarycznym C21H34O3 i masie molowej 334.5 g/mol. Nazwa systematyczna IUPAC: (3S,8R,9S,10R,13S,14S,17R)-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol. InChIKey: XGUQCUDPXSTKLI-JGVMTBIOSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H34O3
Masa molowa334.5 g/mol
Nazwa IUPAC(3S,8R,9S,10R,13S,14S,17R)-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol
InChIKeyXGUQCUDPXSTKLI-JGVMTBIOSA-N
SMILESC[C@H]([C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: (3beta,20R)-Pregn-5-ene-3,17,20-triol, (3b,20R)-Pregn-5-ene-3,17,20-triol, Pregn-5-ene-3beta,17,20beta-triol; 3beta,17alpha,20beta-Trihydroxypregn-5-ene;, Pregn-5-ene-3b,17,20b-triol, 3b,17a,20b-Trihydroxypregn-5-ene, (20R)-Pregn-5-ene-3beta,17,20-triol
Powiązane formy tego związku
(3S,8R,9S,10R,13S,14S,17R)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol C21H34O3
Izomery (ten sam wzór sumaryczny)
methyl (5Z,8Z)-10-[3-[(Z)-oct-2-enyl]oxiran-2-yl]deca-5,8-dienoate C21H34O3
methyl 4-[3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trienyl]oxiran-2-yl]butanoate C21H34O3
methyl (6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoate C21H34O3
1-[(3R,5R,8R,9S,10S,13S,14S,16R,17R)-3,16-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
2-hydroxy-1-[(3S,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
2-hydroxy-1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
1-[(3R,5S,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
1-[(3S,5S,6R,8R,9S,10R,13S,14S,17S)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
1-[(3R,5S,6S,8R,9S,10R,13S,14S,17S)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
1-[(3R,5S,8S,9S,10S,11R,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
1-[(3R,8R,9S,10S,13R,14S,16R,17R)-3,16-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3